183 related articles for article (PubMed ID: 18220076)
1. Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats.
Morairty SR; Hedley L; Flores J; Martin R; Kilduff TS
Sleep; 2008 Jan; 31(1):34-44. PubMed ID: 18220076
[TBL] [Abstract][Full Text] [Related]
2. Effects of serotonergic activation by 5-hydroxytryptophan on sleep and body temperature of C57BL/6J and interleukin-6-deficient mice are dose and time related.
Morrow JD; Vikraman S; Imeri L; Opp MR
Sleep; 2008 Jan; 31(1):21-33. PubMed ID: 18220075
[TBL] [Abstract][Full Text] [Related]
3. Sleep-wake effects following the selective 5-HT(1A) receptor antagonist p-MPPI in the freely moving rat.
Sørensen E; Bjorvatn B; Ursin R
Behav Brain Res; 2000 Sep; 114(1-2):31-8. PubMed ID: 10996044
[TBL] [Abstract][Full Text] [Related]
4. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
Monti JM; Jantos H
Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
[TBL] [Abstract][Full Text] [Related]
5. Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig.
Xi M; Chase MH
Sleep; 2008 Jul; 31(7):1043-51. PubMed ID: 18652100
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
Hemrick-Luecke SK; Evans DC
Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1-like receptor agonists enhance wakefulness.
Dzoljic MR; Ukponmwan OE; Saxena PR
Neuropharmacology; 1992 Jul; 31(7):623-33. PubMed ID: 1407402
[TBL] [Abstract][Full Text] [Related]
8. Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121.
Olive MF; Seidel WF; Edgar DM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1073-83. PubMed ID: 9618410
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxytryptophan, but not L-tryptophan, alters sleep and brain temperature in rats.
Imeri L; Mancia M; Bianchi S; Opp MR
Neuroscience; 2000; 95(2):445-52. PubMed ID: 10658624
[TBL] [Abstract][Full Text] [Related]
10. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
Monti JM; Jantos H
Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
[TBL] [Abstract][Full Text] [Related]
11. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
Ponzoni A; Monti JM; Jantos H
Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for the sleep-promoting effects of 5-HT₂A receptor antagonists and demonstration of synergistic effects with the hypnotic, zolpidem in rats.
Griebel G; Beeské S; Jacquet A; Laufrais C; Alonso R; Decobert M; Avenet P; Françon D
Neuropharmacology; 2013 Jul; 70():19-26. PubMed ID: 23321054
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
Dekeyne A; Girardon S; Millan MJ
Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
[TBL] [Abstract][Full Text] [Related]
15. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
Bjorvatn B; Ursin R
Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
[TBL] [Abstract][Full Text] [Related]
16. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
Griebel G; Perrault G; Sanger DJ
Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
[TBL] [Abstract][Full Text] [Related]
18. The impact of age on the hypnotic effects of eszopiclone and zolpidem in the guinea pig.
Xi M; Chase MH
Psychopharmacology (Berl); 2009 Jul; 205(1):107-17. PubMed ID: 19343329
[TBL] [Abstract][Full Text] [Related]
19. Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats.
Fox SV; Gotter AL; Tye SJ; Garson SL; Savitz AT; Uslaner JM; Brunner JI; Tannenbaum PL; McDonald TP; Hodgson R; Yao L; Bowlby MR; Kuduk SD; Coleman PJ; Hargreaves R; Winrow CJ; Renger JJ
Neuropsychopharmacology; 2013 Nov; 38(12):2401-8. PubMed ID: 23722242
[TBL] [Abstract][Full Text] [Related]
20. Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving rat.
Sørensen E; Grønli J; Bjorvatn B; Bjørkum A; Ursin R
Brain Res; 2001 Apr; 897(1-2):122-30. PubMed ID: 11282365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
